This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Oct;36(8):811-2; author reply 812.

doi: 10.1111/apt.12009.

Letter: Mucosal PCR for cytomegalovirus in refractory ulcerative colitis

T Yoshino, H Nakase, M Matsuura

PMID: 22984956
DOI: 10.1111/apt.12009

Comment

Letter: Mucosal PCR for cytomegalovirus in refractory ulcerative colitis

T Yoshino et al. Aliment Pharmacol Ther. 2012 Oct.

. 2012 Oct;36(8):811-2; author reply 812.

doi: 10.1111/apt.12009.

Authors

T Yoshino, H Nakase, M Matsuura

PMID: 22984956
DOI: 10.1111/apt.12009

No abstract available

PubMed Disclaimer

Comment on

Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
Chaparro M, Burgueño P, Iglesias E, Panés J, Muñoz F, Bastida G, Castro L, Jiménez C, Mendoza JL, Barreiro-de Acosta M, Senent SG, Gomollón F, Calvet X, García-Planella E, Gómez M, Hernández V, Hinojosa J, Mañosa M, Nyssen OP, Gisbert JP. Chaparro M, et al. Aliment Pharmacol Ther. 2012 Jan;35(2):275-83. doi: 10.1111/j.1365-2036.2011.04934.x. Epub 2011 Dec 5. Aliment Pharmacol Ther. 2012. PMID: 22142227

Similar articles

Cytomegalovirus affects clinical outcome of infliximab in ulcerative colitis refractory to tacrolimus.
Nakase H, Yamamoto S, Matsuura M, Honzawa Y, Chiba T. Nakase H, et al. Aliment Pharmacol Ther. 2010 Aug;32(3):510-1. doi: 10.1111/j.1365-2036.2010.04372.x. Aliment Pharmacol Ther. 2010. PMID: 20636704 No abstract available.
Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresis.
Criscuoli V, Mocciaro F, Orlando A, Rizzuto MR, Renda MC, Cottone M. Criscuoli V, et al. Inflamm Bowel Dis. 2009 Jun;15(6):810-1. doi: 10.1002/ibd.20742. Inflamm Bowel Dis. 2009. PMID: 18839422 No abstract available.
Rescue with infliximab and surgical outcomes for refractory ulcerative colitis.
Actis GC, Pellicano R, Pinna-Pintor M, Rizzetto M. Actis GC, et al. J Am Coll Surg. 2007 Oct;205(4):e3-4. doi: 10.1016/j.jamcollsurg.2007.06.319. J Am Coll Surg. 2007. PMID: 17903716 No abstract available.
Treatment of choice for acute severe steroid-refractory ulcerative colitis is remicade.
Halfvarson J, Järnerot G. Halfvarson J, et al. Inflamm Bowel Dis. 2009 Jan;15(1):143-5. doi: 10.1002/ibd.20782. Inflamm Bowel Dis. 2009. PMID: 18942766 Review. No abstract available.
[Anti-TNF-alpha antibody treatment of patients with active ulcerative colitis].
Ainsworth MA, Brynskov J. Ainsworth MA, et al. Ugeskr Laeger. 2007 Feb 26;169(9):789-91. Ugeskr Laeger. 2007. PMID: 17355841 Review. Danish.

See all similar articles

Cited by

Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ulcerative Colitis (UC).
Jentzer A, Veyrard P, Roblin X, Saint-Sardos P, Rochereau N, Paul S, Bourlet T, Pozzetto B, Pillet S. Jentzer A, et al. Microorganisms. 2020 Jul 20;8(7):1078. doi: 10.3390/microorganisms8071078. Microorganisms. 2020. PMID: 32698383 Free PMC article. Review.
Cytomegalovirus and ulcerative colitis: Place of antiviral therapy.
Pillet S, Pozzetto B, Roblin X. Pillet S, et al. World J Gastroenterol. 2016 Feb 14;22(6):2030-45. doi: 10.3748/wjg.v22.i6.2030. World J Gastroenterol. 2016. PMID: 26877608 Free PMC article. Review.
Current Diagnostic and Therapeutic Approaches to Cytomegalovirus Infections in Ulcerative Colitis Patients Based on Clinical and Basic Research Data.
Yokoyama Y, Yamakawa T, Hirano T, Kazama T, Hirayama D, Wagatsuma K, Nakase H. Yokoyama Y, et al. Int J Mol Sci. 2020 Mar 31;21(7):2438. doi: 10.3390/ijms21072438. Int J Mol Sci. 2020. PMID: 32244555 Free PMC article. Review.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information